Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022

OBJECTIVES: We estimated the BNT162b2 vaccine effectiveness (VE) against any (symptomatic or not) SARS-CoV-2 Delta and Omicron infection among adolescents (aged 12-17 years) in Norway from August 2021 to January 2022. METHODS: We used Cox proportional hazard models, where vaccine status was included...

Descripción completa

Detalles Bibliográficos
Autores principales: Veneti, Lamprini, Berild, Jacob Dag, Watle, Sara Viksmoen, Starrfelt, Jostein, Greve-Isdahl, Margrethe, Langlete, Petter, Bøås, Håkon, Bragstad, Karoline, Hungnes, Olav, Meijerink, Hinta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991321/
https://www.ncbi.nlm.nih.gov/pubmed/36893942
http://dx.doi.org/10.1016/j.ijid.2023.03.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991321/
https://www.ncbi.nlm.nih.gov/pubmed/36893942
http://dx.doi.org/10.1016/j.ijid.2023.03.004

Ejemplares similares